Glinta 5 mg contains Linagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor used for the management of type 2 diabetes mellitus. It works by increasing the levels of incretin hormones, which enhance insulin secretion and reduce glucagon secretion in a glucose-dependent manner. This medication helps in controlling blood sugar levels, especially when diet and exercise are insufficient.